Drugs Made Stock Forecast - Double Exponential Smoothing
| DMII Stock | 9.92 0.01 0.10% |
The Double Exponential Smoothing forecasted value of Drugs Made In on the next trading day is expected to be 9.92 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.24. Drugs Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Drugs Made's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 13th of January 2026 the relative strength index (rsi) of Drugs Made's share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Drugs Made hype-based prediction, you can estimate the value of Drugs Made In from the perspective of Drugs Made response to recently generated media hype and the effects of current headlines on its competitors.
The Double Exponential Smoothing forecasted value of Drugs Made In on the next trading day is expected to be 9.92 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.24. Drugs Made after-hype prediction price | USD 9.92 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Drugs Made to cross-verify your projections. Drugs Made Additional Predictive Modules
Most predictive techniques to examine Drugs price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Drugs using various technical indicators. When you analyze Drugs charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Drugs Made Double Exponential Smoothing Price Forecast For the 14th of January 2026
Given 90 days horizon, the Double Exponential Smoothing forecasted value of Drugs Made In on the next trading day is expected to be 9.92 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.0002, and the sum of the absolute errors of 0.24.Please note that although there have been many attempts to predict Drugs Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Drugs Made's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Drugs Made Stock Forecast Pattern
| Backtest Drugs Made | Drugs Made Price Prediction | Buy or Sell Advice |
Drugs Made Forecasted Value
In the context of forecasting Drugs Made's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Drugs Made's downside and upside margins for the forecasting period are 9.76 and 10.07, respectively. We have considered Drugs Made's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Drugs Made stock data series using in forecasting. Note that when a statistical model is used to represent Drugs Made stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.0028 |
| MAD | Mean absolute deviation | 0.0094 |
| MAPE | Mean absolute percentage error | 0.001 |
| SAE | Sum of the absolute errors | 0.2356 |
Predictive Modules for Drugs Made
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Drugs Made In. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Drugs Made
For every potential investor in Drugs, whether a beginner or expert, Drugs Made's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Drugs Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Drugs. Basic forecasting techniques help filter out the noise by identifying Drugs Made's price trends.Drugs Made Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Drugs Made stock to make a market-neutral strategy. Peer analysis of Drugs Made could also be used in its relative valuation, which is a method of valuing Drugs Made by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Drugs Made In Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Drugs Made's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Drugs Made's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Drugs Made Market Strength Events
Market strength indicators help investors to evaluate how Drugs Made stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Drugs Made shares will generate the highest return on investment. By undertsting and applying Drugs Made stock market strength indicators, traders can identify Drugs Made In entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 9.92 | |||
| Day Typical Price | 9.92 | |||
| Price Action Indicator | 0.005 | |||
| Period Momentum Indicator | 0.01 |
Drugs Made Risk Indicators
The analysis of Drugs Made's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Drugs Made's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting drugs stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.1006 | |||
| Standard Deviation | 0.161 | |||
| Variance | 0.0259 | |||
| Downside Variance | 0.0373 | |||
| Semi Variance | (0) | |||
| Expected Short fall | (0.20) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Drugs Made In is a strong investment it is important to analyze Drugs Made's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Drugs Made's future performance. For an informed investment choice regarding Drugs Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Drugs Made to cross-verify your projections. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Diversified Capital Markets space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Drugs Made. If investors know Drugs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Drugs Made listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Drugs Made In is measured differently than its book value, which is the value of Drugs that is recorded on the company's balance sheet. Investors also form their own opinion of Drugs Made's value that differs from its market value or its book value, called intrinsic value, which is Drugs Made's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Drugs Made's market value can be influenced by many factors that don't directly affect Drugs Made's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Drugs Made's value and its price as these two are different measures arrived at by different means. Investors typically determine if Drugs Made is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Drugs Made's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.